Ken Griffin Abcam PLC Call Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$21.54 - $24.41 $934,836 - $1.06 Million
43,400 Added 377.39%
54,900 $1.24 Million
Q2 2023

Aug 14, 2023
BUY
$12.62 - $24.47 $71,934 - $139,479
5,700 Added 98.28%
11,500 $281,000
Q1 2023

May 15, 2023
BUY
$12.98 - $17.1 $72,688 - $95,760
5,600 Added 2800.0%
5,800 $78,000
Q4 2022

Feb 14, 2023
BUY
$13.92 - $17.0 $2,784 - $3,400
200 New
200 $3,000

Others Institutions Holding ABCM

# of Institutions
4
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Abcam plc

ABCM Quotes by TradingView
  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email